Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
for ALK Positive
Drug: NXP900
1 location in Fairfax
Sponsor: Nuvectis Pharma, Inc.
Sex: All·Age: All ages
Code: NCT07784959·Phase 1·Recruiting·Listed Aug 25, 2026
Non-small cell lung cancer (NSCLC) Clinical Trials in Fairfax, VA
As of August 2026, 69 paid clinical trials are recruiting for Non-small cell lung cancer (NSCLC) in Fairfax, Virginia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Fairfax
Filter results
Filter results
Newly added in Fairfax
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
70 clinical trials for Non-small cell lung cancer (NSCLC)
·Clear filters· Email me when a new non-small cell lung cancer (nsclc) trial opens in Fairfax, VA.
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
for Non-small Cell Lung Cancer
Drug: Zongertinib
Sites in Fairfax +26 more locations
Sponsor: Boehringer Ingelheim
Sex: All·Age: 18+
Code: NCT07195695·Phase 3·Recruiting·Listed Sep 2025
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for Carcinoma, Non-Small-Cell Lung
Drug: Amivantamab
Sites in Fairfax +124 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT06667076·Phase 2·Recruiting·Listed Oct 2024
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY3537982
Sites in Fairfax, Charlottesville +86 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06119581·Phase 3·Recruiting·Listed Nov 2023
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
for NSCLC (Non-small Cell Lung Cancer)
Drug: daraxonrasib
Sites in Fairfax +42 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06881784·Phase 3·Recruiting·Listed Mar 2025
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for Non-Small Cell Lung Cancer
Drug: Telisotuzumab Vedotin
Sites in Fairfax +36 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06568939·Phase 2·Recruiting·Listed Aug 2024
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
for Carcinoma, Non-Small-Cell Lung
Drug: Intismeran autogene
Sites in Fairfax, Richmond +48 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06623422·Phase 3·Recruiting·Listed Oct 2024
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
for Non-small Cell Lung Cancer
Drug: Intismeran autogene
Sites in Fairfax +57 more locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06077760·Phase 3·Recruiting·Listed Oct 2023
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
for High Grade Epithelial Ovarian Cancer
Sites in Fairfax, Norfolk +35 more locations
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT05579366·Phase 1, Phase 2·Recruiting·Listed Oct 2022
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
for Carcinoma, Non-small-Cell Lung
Drug: Amivantamab
Sites in Fairfax +13 more locations
Sponsor: Janssen Research & Development, LLC
Sex: All·Age: 18+
Code: NCT05498428·Phase 2·Recruiting·Listed Aug 2022
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
for Advanced Solid Tumor
Sites in Fairfax +23 more locations
Sponsor: Synthekine
Sex: All·Age: 18+
Code: NCT05098132·Phase 1, Phase 2·Recruiting·Listed Oct 2021
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
for Non-small Cell Lung Cancer
Sites in Fairfax, Arlington +36 more locations
Sponsor: BioNTech SE
Sex: All·Age: 18+
Code: NCT06712316·Phase 2, Phase 3·Recruiting·Listed Dec 2024
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)
for Non-small Cell Lung Cancer
Sites in Fairfax +22 more locations
Sponsor: Genentech, Inc.
Sex: All·Age: 18+
Code: NCT04302025·Phase 2·Recruiting·Listed Mar 2020
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
for Carcinoma, Non-Small-Cell Lung
Sites in Fairfax +24 more locations
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All·Age: 18+
Code: NCT05208762·Phase 1·Recruiting·Listed Jan 2022
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for Non-Small Cell Lung Cancer
Drug: Ivonescimab
Sites in Fairfax, Charlottesville +92 more locations
Sponsor: Summit Therapeutics
Sex: All·Age: 18+
Code: NCT06767514·Phase 3·Recruiting·Listed Jan 2025
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
for Advanced Solid Tumor
Sites in Fairfax +30 more locations
Sponsor: PMV Pharmaceuticals, Inc
Sex: All·Age: 12+
Code: NCT04585750·Phase 1, Phase 2·Recruiting·Listed Oct 2020
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
for Mesothelioma
Drug: MRTX1719
Sites in Fairfax +21 more locations
Sponsor: Bristol-Myers Squibb
Sex: All·Age: 18+
Code: NCT05245500·Phase 1·Recruiting·Listed Feb 2022
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for ER+, HER 2- Breast Cancer
Sites in Fairfax +10 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18 - 99
Code: NCT07540572·Phase 1·Recruiting·Listed Apr 2026
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for Esophageal Squamous Cell Carcinoma
Sites in Fairfax +14 more locations
Sponsor: IDEAYA Biosciences
Sex: All·Age: 18+
Code: NCT07503808·Phase 1·Recruiting·Listed Mar 2026
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer (NSCLC)
Sites in Fairfax +18 more locations
Sponsor: Genmab
Sex: All·Age: 18+
Code: NCT07288177·Phase 2·Recruiting·Listed Dec 2025
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
for Non-small Cell Lung Cancer
Sites in Fairfax +21 more locations
Sponsor: Nuvalent Inc.
Sex: All·Age: 18+
Code: NCT06765109·Phase 3·Recruiting·Listed Jan 2025
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for Metastatic Solid Tumor
Sites in Fairfax +15 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT06561685·Phase 1·Recruiting·Listed Aug 2024
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
for Non-Small Cell Lung Cancer (NSCLC)
Drug: daraxonrasib
Sites in Fairfax +19 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06128551·Phase 1, Phase 2·Recruiting·Listed Nov 2023
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
for NSCLC
Drug: EP0031
Sites in Fairfax +14 more locations
Sponsor: Ellipses Pharma
Sex: All·Age: 18+
Code: NCT05443126·Phase 1, Phase 2·Recruiting·Listed Jul 2022
A Study of LY4175408 in Participants With Advanced Cancer
for Carcinoma, Non-Small-Cell Lung
Drug: LY4175408
Sites in Fairfax +14 more locations
Sponsor: Eli Lilly and Company
Sex: All·Age: 18+
Code: NCT07046923·Phase 1·Recruiting·Listed Jul 2025
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
for High-Grade Serous Ovarian Cancer
Drug: Bevacizumab
Sites in Fairfax +19 more locations
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT05005403·Phase 1·Recruiting·Listed Aug 2021
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for Non-small Cell Lung Cancer (NSCLC)
Sites in Fairfax +11 more locations
Sponsor: Nuvation Bio Inc.
Sex: All·Age: 18+
Code: NCT07154706·Phase 3·Recruiting·Listed Sep 2025
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
for Non-small Cell Lung Cancer (NSCLC)
Sites in Fairfax +16 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT06040541·Phase 1·Recruiting·Listed Sep 2023
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
for Non-small Cell Lung Cancer (NSCLC)
Sites in Fairfax +20 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT05379985·Phase 1, Phase 2·Recruiting·Listed May 2022
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
for PDAC
Sites in Fairfax +17 more locations
Sponsor: Tango Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06922591·Phase 1, Phase 2·Recruiting·Listed Apr 2025
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
for Non-small Cell Lung Cancer
Sites in Fairfax +21 more locations
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Sex: All·Age: 18+
Code: NCT06343402·Phase 1·Recruiting·Listed Apr 2024
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
for Pancreatic Ductal Adenocarcinoma
Sites in Fairfax, Charlottesville +11 more locations
Sponsor: Verastem, Inc.
Sex: All·Age: 18+
Code: NCT07020221·Phase 1, Phase 2·Recruiting·Listed Jun 2025
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
for Oncology
Sites in Fairfax +12 more locations
Sponsor: Nested Therapeutics, Inc
Sex: All·Age: 18+
Code: NCT06326411·Phase 1·Recruiting·Listed Mar 2024
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
for Non Small Cell Lung Cancer
Sites in Fairfax +14 more locations
Sponsor: Tango Therapeutics, Inc.
Sex: All·Age: 18+
Code: NCT06810544·Phase 1, Phase 2·Recruiting·Listed Feb 2025
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
for Advanced Solid Tumors With KRAS G12C Mutations
Drug: FMC-376
Sites in Fairfax +11 more locations
Sponsor: Frontier Medicines Corporation
Sex: All·Age: 18+
Code: NCT06244771·Phase 1, Phase 2·Recruiting·Listed Feb 2024
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
for Solid Tumor Malignancies
Sites in Fairfax +12 more locations
Sponsor: Tasca Therapeutics
Sex: All·Age: 18+
Code: NCT07030257·Phase 1, Phase 2·Recruiting·Listed Jun 2025
A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
for Advanced or Metastatic Solid Tumors
Sites in Fairfax +9 more locations
Sponsor: Incendia Therapeutics
Sex: All·Age: 18+
Code: NCT05753722·Phase 1·Recruiting·Listed Mar 2023
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
for Non Small Cell Lung Cancer
Sites in Fairfax +23 more locations
Sponsor: SystImmune Inc.
Sex: All·Age: 18+
Code: NCT05983432·Phase 1·Recruiting·Listed Aug 2023
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
for Solid Tumor, Adult
Sites in Fairfax +12 more locations
Sponsor: GV20 Therapeutics
Sex: All·Age: 18+
Code: NCT05669430·Phase 1, Phase 2·Recruiting·Listed Dec 2022
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
for Advanced Solid Tumor
Sites in Fairfax +2 more locations
Sponsor: Blueprint Medicines Corporation
Sex: All·Age: 18+
Code: NCT07629960·Phase 1, Phase 2·Recruiting·Listed Jun 2026
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
for Advanced Solid Tumors
Drug: Ivonescimab
Sites in Fairfax +8 more locations
Sponsor: Revolution Medicines, Inc.
Sex: All·Age: 18+
Code: NCT07397338·Phase 1, Phase 2·Recruiting·Listed Feb 2026
Top Research Study Locations in Fairfax
Researchers run research studies in Fairfax, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| NEXT Virginia | Advanced Solid Tumor, Advanced Solid Tumors, Solid Tumor | 75 |
| Virginia Cancer Specialists | Breast Cancer, Endometrial Cancer, Ovarian Cancer | 65 |
| Inova Schar Cancer Institute | Breast Cancer, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 55 |
| NEXT Oncology Virginia | Colorectal Cancer, Advanced Solid Tumors, Cancer | 28 |
| NEXT Oncology | Solid Tumor, Ovarian Cancer, Breast Cancer | 24 |
| Virginia Cancer Specialists, PC | Breast Cancer, Esophageal Adenocarcinoma, Metastatic Breast Cancer | 15 |
| Inova Fair Oaks Hospital | Ovarian Carcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 | 13 |
| Re:Cognition Health | Alcohol Use Disorder, Alzheimers Disease, Amyloid | 7 |
| Inova Schar Cancer | Advanced Or Metastatic Merkel Cell Carcinoma, Colorectal Cancer, Cutaneous Melanoma | 7 |
| Inova Fairfax Hospital | Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Cardiovascular Diseases | 6 |
| NEXT Oncology - Virginia | Advanced Solid Tumors, CNS Tumor, Cholangiocarcinoma | 4 |
| NEXT Oncology - Virginia Cancer Specialists | Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, CNS Metastases | 4 |
| O & O Alpan | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 4 |
| Virginia Cancer Specialists PC | Anaplastic Lymphoma Kinase (ALK) Positive, Extensive Stage Small-cell Lung Cancer, Metastatic Castration-resistant Prostate Cancer | 4 |
| Dren Investigational Site | Aggressive NK Cell Leukemia, Aplastic Anemias, Bone Marrow Failure Syndromes | 3 |
| George Mason University | Hiv, Major Depressive Disorder (MDD), Mental Health Issue | 3 |
| Inova Health Care Services | Angina, Calcium Release Deficiency Syndrome, Femoral Neck Fractures | 3 |
| Inova Health System | Cervical Cancer, Coronary Artery Disease Progression, Coronary Artery Disease Risk Factors Multiple | 3 |
| Inova Schar Cancer Institute Clinical Trials | Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | 3 |
| Lysosomal Rare Disorders Research and Treatment Center | Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis | 3 |
| Lysosomal and Rare Disorders Research and Treatment Center, Inc. | Fabry Disease, Pompe Disease | 3 |
| The Retina Group of Washington | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 3 |
| Avenzo Therapeutics Recruiting Site | Biliary Tract Cancer (BTC), Epithelial Tumor, HR+, HER2-, Advanced Breast Cancer | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer | 2 |
| Clinical Trial Site | Advanced Solid Tumor, High Cardiovascular Risk, High Risk Cardiovascular Disease | 2 |
Active & Upcoming Studies in Fairfax (2026)
Recruiting trials in Fairfax grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (333 active studies)
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02) · Phase 3 · Bristol-Myers Squibb
- Study of Oral MRT-2359 With Apalutamide in Prostate Cancer · Phase 2 · Monte Rosa Therapeutics, Inc
Cardiovascular (8 active studies)
- PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis · Phase 3 · Duke University
- Palliative Care Intervention to Improve Health Related Quality of Life for Patients on Long-Term LVAD Support · Medstar Health Research Institute
Neurology & pain (4 active studies)
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease · Phase 2 · Lighthouse Pharmaceuticals, Inc.
- A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease · Phase 4 · Impax Laboratories, LLC
Mental health & behavior (3 active studies)
- ALTO-207 in Adults With Treatment-resistant Depression (TRD) · Phase 2 · Alto Neuroscience
- A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1) · Phase 2 · Eli Lilly and Company
Eye & vision (3 active studies)
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy · Astellas Pharma Global Development, Inc.
Diabetes & metabolic (2 active studies)
HIV / STI (1 active study)
- PrEP Intervention in Prince George's County, Maryland · George Mason University
Common conditions studied in Fairfax
- Advanced Solid Tumor (33 active studies)
- Ovarian Cancer (28 active studies)
- Endometrial Cancer (26 active studies)
- Advanced Solid Tumors (25 active studies)
- Breast Cancer (23 active studies)
- Colorectal Cancer (21 active studies)
Leading research sponsors in Fairfax
- AstraZeneca
- AbbVie
- Merck Sharp & Dohme LLC
- Eli Lilly and Company
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Fairfax?
There are approximately 492 recruiting clinical trials in Fairfax, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fairfax pay participants?
Most recruiting trials in Fairfax compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fairfax?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fairfax?
The most common conditions under active study in Fairfax include Advanced Solid Tumor (33), Ovarian Cancer (28), Endometrial Cancer (26), Advanced Solid Tumors (25), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fairfax?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fairfax on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fairfax?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fairfax?
Recruiting research sites in Fairfax include NEXT Virginia, Virginia Cancer Specialists, Inova Schar Cancer Institute, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fairfax right now?
The largest active categories in Fairfax are Cancer & tumors (333), Cardiovascular (8), Neurology & pain (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
Browse more clinical trials
Other cities in Virginia
Richmond, VA(582)Charlottesville, VA(530)Norfolk, VA(294)Roanoke, VA(156)Falls Church, VA(124)Lynchburg, VA(56)Midlothian, VA(51)Newport News, VA(46)Winchester, VA(44)Manassas, VA(41)Virginia Beach, VA(40)Salem, VA(35)Arlington, VA(34)South Hill, VA(31)Blacksburg, VA(27)Mechanicsville, VA(27)McLean, VA(22)Chesapeake, VA(21)Fredericksburg, VA(18)Alexandria, VA(17)Williamsburg, VA(17)Woodbridge, VA(15)Leesburg, VA(14)Vienna, VA(14)Burke, VA(13)Hampton, VA(13)Wytheville, VA(13)Portsmouth, VA(11)Reston, VA(11)Fishersville, VA(9)Fort Belvoir, VA(9)Suffolk, VA(9)Tappahannock, VA(9)Bristol, VA(8)Low Moor, VA(8)Henrico, VA(7)Martinsville, VA(6)Petersburg, VA(6)Annandale, VA(5)Danville, VA(5)Gainesville, VA(4)Christiansburg, VA(3)Franklin, VA(3)Lansdowne Town Center, VA(3)North Chesterfield, VA(3)Norton, VA(3)Washington, VA(3)Gloucester, VA(2)Hopewell, VA(2)Warrenton, VA(2)Culpeper, VA(1)Faifax, VA(1)Forest, VA(1)Glen Allen, VA(1)Gordonsville, VA(1)Harrisonburg, VA(1)Haymarket, VA(1)Herndon, VA(1)Langley Air Force Base, VA(1)Lansdowne, VA(1)